Is NPH associated with fewer adverse events than analog basal insulin for adults with T2D?

Corey Lyon, Swetha Iruku, Molly Hoss, Kristen DeSanto, Rick Guthmann, Advocate Family Medicine Faculty - Illinois Masonic

Research output: Contribution to journalArticlepeer-review

Abstract

NO. Insulin glargine may lead to less patient-reported, symptomatic, and nocturnal hypoglycemia, although overall, there may not be a difference in the risk for severe hypoglycemia orhypoglycemiarelated emergency department (ED) visits and hospitalizations (strength of recommendation [SOR]: B, systematic review of randomized controlled trials [RCTs], individual RCTs, and observational study).

Original languageAmerican English
JournalJournal of Family Practice
DOIs
StatusPublished - May 1 2021

Keywords

  • Adult
  • Aged
  • 80 and over
  • Diabetes Mellitus
  • Type 2
  • Female
  • Humans
  • Hypoglycemia
  • Insulin Glargine
  • Insulin
  • Isophane
  • Male
  • Middle Aged
  • Treatment Outcome

Cite this